Impeding the combination of astrocytic ASCT2 and NLRP3 by talniflumate alleviates neuroinflammation in experimental models of Parkinson's disease
2022 · Acta Pharmaceutica Sinica B · 29 citations
https://doi.org/10.1016/j.apsb.2022.07.021
Y
Yang Liu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
620
Citations
12
h-index
16
i10-index
Yang Liu is an academic researcher from University of Southern California. The author has contributed to research in topics: Epigenetics and DNA Methylation & Parkinson's Disease Mechanisms and Treatments & Tryptophan and brain disorders. The author has an h-index of 12, co-authored 24 publications.
ORCID: 0000-0003-4243-2330Papers by this author
worksThe interplay between α-Synuclein and NLRP3 inflammasome in Parkinson's disease
2023 · Biomedicine & Pharmacotherapy · 27 citations
https://doi.org/10.1016/j.biopha.2023.115735
Mitochondrial glutamine transporter SLC1A5_var, a potential target to suppress astrocyte reactivity in Parkinson’s Disease
2022 · Cell Death and Disease · 25 citations
https://doi.org/10.1038/s41419-022-05399-z
Combined targeting of glioblastoma stem cells of different cellular states disrupts malignant progression
2025 · Nature Communications · 16 citations
https://doi.org/10.1038/s41467-025-58366-5
Inactivation of NLRP3 inflammasome by dephosphorylation at Serine 658 alleviates glial inflammation in the mouse model of Parkinson’s disease
2025 · Molecular Neurodegeneration · 12 citations
https://doi.org/10.1186/s13024-025-00818-z
Hsa_circ_0001326 regulates proliferation, migration, invasion, and EMT of HTR‐8/SVneo cells via increasing IL16 expression
2021 · American Journal of Reproductive Immunology · 10 citations
https://doi.org/10.1111/aji.13484
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat